OrthoPediatrics (KIDS)
(Delayed Data from NSDQ)
$32.60 USD
-0.26 (-0.79%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $32.66 +0.06 (0.18%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
KIDS 32.60 -0.26(-0.79%)
Will KIDS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for KIDS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for KIDS
OrthoPediatrics (KIDS) Soars 7.5%: Is Further Upside Left in the Stock?
CVRx (CVRX) Stock Jumps 33.9%: Will It Continue to Soar?
KIDS: What are Zacks experts saying now?
Zacks Private Portfolio Services
OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for KIDS
OrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024
OrthoPediatrics price target lowered by $3 at Truist, here's why
OrthoPediatrics Breaks Below 200-Day Moving Average - Notable for KIDS
Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS), Pharvaris (PHVS) and Cue Biopharma (CUE)
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference